Roivant Sciences ROIV
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 6th percentile, 5-year average -18.3x
Near the top of its 5-year range · 84th percentile, 5-year average 3.8x
#4801 of 5338 stocks by PB (1 = cheapest)
Above its usual level · 79th percentile, 5-year average 514.3x
#5087 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 6.97 | – | 3.81 | 84% (pricier than usual) | #4801 of 5338 (1 = cheapest) |
| PE | -66.65 | -33.76 | -18.27 | 6% (cheaper than usual) | – |
| PS | 681.76 | 74.21 | 514.34 | 79% (pricier than usual) | #5087 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ROIV.
Sign in to join the discussion.